Literature DB >> 2609889

Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report.

C Biondi Oriente1, R Scarpa, A Pucino, P Oriente.   

Abstract

Six hundred and forty-seven patients with psoriasis were studied in order to define prevalence and clinical features of psoriasis and psoriatic arthritis. After medical history review all patients were observed by a dermatologist and a rheumatologist. Successive laboratory tests and radiological and scintiscan examinations of joints were also performed. Diagnosis of arthritis was made according to Wright and Moll. In our district, the prevalence of psoriasis in respect to other dermatological diseases was 1.86%. Vulgaris pattern occurred in 85% of the total cases while eruptive was found in 10.5%. Erythrodermic and pustular forms were uncommon, occurring in 2.47% and in 1.23%, respectively. In 84.8% of the total cases, psoriasis onset was clinically evident while in 10.8% it affected non-evident cutaneous sites. Onycopathic onset occurred in 4.3%. Altogether 138 psoriatic patients exhibited arthritis and spondylitic and polyarticular patterns were very common (occurring in 42.7% and 33.3%, respectively). Psoriasis antedated arthritis in 68.4% of the cases but followed it in 21%. Synchronous onset occurred in 10.8%. The data obtained strengthen those of our previous reports. In particular, the marked articular involvement of psoriatic patients is confirmed. Moreover, our results, when compared with data of other authors, show a different distribution among the arthritic subtypes.

Entities:  

Mesh:

Year:  1989        PMID: 2609889

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  17 in total

1.  TNFalpha therapy in psoriatic arthritis and psoriasis.

Authors:  P Mease
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

2.  Classification and categorisation of psoriatic arthritis.

Authors:  Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2008-07-16       Impact factor: 2.980

Review 3.  Safety of etanercept in psoriasis: a critical review.

Authors:  Jose L Sánchez Carazo; Laura Mahiques Santos; Vicente Oliver Martinez
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Secukinumab: A New Treatment Option for Psoriatic Arthritis.

Authors:  Philip Mease; Iain B McInnes
Journal:  Rheumatol Ther       Date:  2016-04-23

5.  Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.

Authors:  C Antoni; G G Krueger; K de Vlam; C Birbara; A Beutler; C Guzzo; B Zhou; L T Dooley; A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-01-27       Impact factor: 19.103

Review 6.  Classification and diagnostic criteria for psoriatic arthritis.

Authors:  P S Helliwell; W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 7.  Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.

Authors:  P J Mease
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

8.  Cytokine blockers in psoriatic arthritis.

Authors:  P J Mease
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 9.  Development of diagnostic criteria for psoriatic arthritis: methods and process.

Authors:  William J Taylor; Philip S Helliwell
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

10.  Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis?

Authors:  Raffaele Scarpa; Francesco Manguso; Alfonso Oriente; Rosario Peluso; Mariangela Atteno; Pasquale Oriente
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.